IP Library Patent Application 16990827
Patent Application
App. No. 16/990,827

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/990,827
Abstract

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): wherein L 1 , A, X 1 , X 2 , R 1 , R 2 , and R 3 are described herein.

Claims (27)

1 . A compound of Formula I:

or a salt thereof,

wherein:

one of X 1 or X 2 is NR x or N + (O − )R x and the other is CHR y or C(O);

R x is

R y is H, alkyl, cycloalkyl or cycloalkylalkyl wherein said alkyl, cycloalkyl and cycloalkylalkyl are optionally substituted with halogen or alkoxy;

L 1 is —(CH 2 ) m (C═O)— or —(CH 2 ) p —;

L 2 is a bond or —S(O) 2 —;

A is cycloalkyl, aryl, heterocycloalkyl or heteroaryl, wherein the cycloalkyl, aryl, heterocycloalkyl, or heteroaryl is optionally substituted with one or more R 7 ;

B is aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more R 5 ;

R 1 and R 2 are each independently H, alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, cycloalkyl, or CN, wherein the cycloalkyl is optionally substituted with one or more R 9 ;

or when A is cycloalkyl or heterocycloalkyl, R 1 and R 2 together when attached to the same carbon atom form a spirocycloalkyl ring optionally substituted with one or more R 8 ; or when A is cycloalkyl or heterocycloalkyl, R 1 and R 2 together when attached to the same atom form a spiroheterocycloalkyl ring optionally substituted with one or more R 8 ; or R 1 and R 2 when on adjacent atoms together with the atoms to which they are attached form a cycloalkyl ring optionally substituted with one or more R 8 ; or R 1 and R 2 when on adjacent atoms together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 8 ; or R 1 and R 2 when on adjacent atoms together with the atoms to which they are attached form an aryl ring optionally substituted with one or more R 8 ; or R 1 and R 2 when on adjacent atoms together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 8 ; or when A is cycloalkyl or heterocycloalkyl, R 1 and R 2 when on non-adjacent atoms, together with the atoms to which they are attached form a cycloalkyl ring optionally substituted with one or more R 8 ; or when cycloalkyl or heterocycloalkyl, R 1 and R 2 when on non-adjacent atoms, together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 8 ; cycloalkyl ring optionally substituted with one or more R 8 ; or when cycloalkyl or heterocycloalkyl, R 1 and R 2 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 8 ;

R 3 is alkyl, alkoxy, haloalkyl, haloalkoxy, hydroxyalkyl, or cycloalkyl optionally substituted with one or more substituents each independently selected from the group consisting of halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, and —OH;

R 4 is COOR 6a , —(CH 2 ) n —COOR 6a , CONR 6b OH, CONR 6b R 6c , CONH(CH 2 ) n COOR 6a , CONH(CH 2 ) n R 6a , —(CH 2 ) n CONH(CH 2 ) n R 6a , CONR 6b SO 2 R 6d , CONR 6b SO 2 (CH 2 ) n R 6d , —(CH 2 ) n —CONR 6b SO 2 R 6d , CONR 6b SO 2 (CH 2 ) n N(CO)R 6d CONH(CH 2 ) n SO 2 R 6e , COR 6f , (CH 2 ) n PO(OR 6g ) 2 , CONR 6b (CH 2 ) n PO(OR 6g ) 2 , CONR 6b SO 2 (CH 2 ) n N + (R 6f ) 3 , COO(CH 2 ) n PO(OR 6g ) 2 , SO 2 NR 6b (CH 2 ) n COOR 6a , SO 2 R 6e , CN, —(CH 2 ) n —NR 6b C(O)R 6c , —(CH 2 ) n —N(OH)—C(O)R 6c , oxo, alkyl, cycloalkyl, —(CH 2 ) n -cycloalkyl, heterocycloalkyl, —(CH 2 ) n -heterocycloalkyl, heteroaryl or —(CH 2 ) n -heteroaryl; wherein said alkyl, cycloalkyl, —(CH 2 ) n -cycloalkyl, heterocycloalkyl, —(CH 2 ) n -heterocycloalkyl, heteroaryl and —(CH 2 ) n -heteroaryl are optionally substituted with COOR 6a , —(CH 2 ) n —COOR 6a , CONR 6b OH, CONR 6b R 6c , CONH(CH 2 ) n COOR 6a , CONH(CH 2 ) n R 6a , —(CH 2 ) n CONH(CH 2 ) n R 6a , CONR 6b SO 2 R 6d , CONR 6b SO 2 (CH 2 ) n R 6d , —(CH 2 ) n —CONR 6b SO 2 R 6d , CONR 6b SO 2 (CH 2 ) n N(CO)R 6d CONH(CH 2 ) n SO 2 R 6e , COR 6f , (CH 2 ) n PO(OR 6g ) 2 , COO(CH 2 ) n PO(OR 6g ) 2 , SO 2 NR 6b (CH 2 ) n COOR 6a , SO 2 R 6e , CN, —(CH 2 ) n —NR 6b C(O)R 6c , or —(CH 2 ) n —N(OH)—C(O)R 6c ;

each R 5 is independently at each occurrence halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, CN, cycloalkyl, spiroheterocycloalkyl, —O-cycloalkyl, —O-heterocycloalkyl, aryl, heterocycloalkyl, or heteroaryl wherein the cycloalkyl, aryl, heterocycloalkyl or heteroaryl are optionally substituted with one or more substituents each independently selected from the group consisting of halogen, alkyl, haloalkyl, alkoxy, and haloalkoxy;

R 6a is H, alkyl, cycloalkyl, aryl, heterocycloalkyl, or heteroaryl; wherein the alkyl, cycloalkyl, aryl, heterocycloalkyl, or heteroaryl is optionally substituted with one or more substituents each independently selected from the group consisting of halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, NR 6b R 6c , SO 2 NR 6b R 6c , and —OH;

R 6b and R 6c are each independently H, alkyl, haloalkyl, cycloalkyl, aryl, heterocycloalkyl, or heteroaryl; wherein the alkyl, cycloalkyl, aryl, heterocycloalkyl, or heteroaryl is optionally substituted with one or more substituents each independently selected from the group consisting of halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, and —OH;

R 6d is alkyl, haloalkyl, cycloalkyl, aryl, heterocycloalkyl or heteroaryl; wherein the alkyl, cycloalkyl, aryl, heterocycloalkyl, or heteroaryl is optionally substituted with one or more substituents each independently selected from the group consisting of halogen, COOH, alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkoxy, —O—CO-alkyl, —O—COcycloalkyl, —O—CO-alkyl-COOH, NR 6b R 6c , NR 6f CO-alkyl, NR 6f CO-alkoxy, cycloalkyl, heterocycloalkyl and —OH;

R 6e is —OH, alkyl, haloalkyl, cycloalkyl, aryl, heterocycloalkyl or heteroaryl; wherein the alkyl, cycloalkyl, aryl, heterocycloalkyl, or heteroaryl is optionally substituted with one or more substituents each independently selected from the group consisting of halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, and —OH;

R 6f is alkyl or haloalkyl;

R 6g is H or alkyl optionally substituted with —O—CO-alkyl;

each R 7 is independently at each occurrence OH, alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, or CN;

each R 8 is independently at each occurrence alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, or —OH;

each R 9 is independently at each occurrence alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, or —OH;

m is 0, 1, or 2;

n is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12; and

p is 1 or 2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2021
From: CHAO, JIANHUA; JAIN, RAKESH; HU, LILY; LEWIS, JASON G; BARIBAULT, HELENE; CALDWELL, JEREMY
To: ARDELYX, INC.
Reel/Frame 057080/0924 →